Dark Forest Capital Management’s Pacira BioSciences PCRX Stock Holding History

Dark Forest Capital Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-19,542	Closed	-$504K	–	1253
2025 Q3	$504K	Sell	19,542 -41,670	-68%	-$1.02M	0.02%	922
2025 Q2	$1.46M	Buy	+61,212	New	+$1.54M	0.06%	594
2025 Q1	–	Sell	-11,658	Closed	-$220K	–	1383
2024 Q4	$220K	Sell	11,658 -131	-1%	-$2.3K	0.03%	794
2024 Q3	$177K	Buy	+11,789	New	+$202K	0.02%	890
2023 Q2	–	Sell	-1,968	Closed	-$80.3K	–	1299
2023 Q1	$80.3K	Buy	1,968 +1,044	+113%	+$41.5K	0.02%	725
2022 Q4	$35.7K	Buy	924 +923	+92,300%	+$44.9K	0.01%	454
2022 Q3	$0	Sell	1 -16	-94%	-$890	﹤0.01%	1364
2022 Q2	$1K	Buy	+17	New	+$1.11K	﹤0.01%	813
2022 Q1	–	Sell	-7	Closed	–	–	1637
2021 Q4	$0	Sell	7 -73	-91%	-$4.03K	﹤0.01%	1696
2021 Q3	$4K	Buy	+80	New	+$4.61K	﹤0.01%	1116

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dark Forest Capital Management's PCRX Position: Q4 2025 in Review

Dark Forest Capital Management sold out of Pacira BioSciences (PCRX) in Q4 2025, closing a stake of 19,542 shares — an estimated $504K sold.

Dark Forest Capital Management first reported a position in PCRX in Q3 2021 and held it in 10 quarters. The position peaked at $1.46M in Q2 2025. 260 funds tracked by Wall St. Rank hold PCRX as of Q4 2025.

Dark Forest Capital Management reported no remaining Pacira BioSciences position as of Q4 2025 after selling out during the quarter.
Dark Forest Capital Management sold 19,542 Pacira BioSciences shares in Q4 2025, an estimated $504K.
Dark Forest Capital Management first reported a position in Pacira BioSciences in Q3 2021 and held it in 10 quarters.
Dark Forest Capital Management's Pacira BioSciences position peaked at $1.46M in Q2 2025.
260 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2025.

Based on Dark Forest Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.